Home Semiconductor & Electronics Electronic Components Cardiac Biomarkers Market

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Myocardial Muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Others), By Application (Acute Coronary Syndrome, Myocardial Infarction, Congestive Heart Failure, Others), By End-User (Laboratory Testing, Point of Care Testing, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: December 12, 2025 | Author: Debashree B | Format: | Report Code: SR3347DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Cardiac Biomarkers Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Myocardial Muscle Creatine Kinase (CK-MB)
    2. Troponins (T and I)
    3. Myoglobin
    4. Others
  2. Cardiac Biomarkers Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Acute Coronary Syndrome
    2. Myocardial Infarction
    3. Congestive Heart Failure
    4. Others
  3. Cardiac Biomarkers Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Laboratory Testing
    2. Point of Care Testing
    3. Others
  4. Regional Cardiac Biomarkers Market
    1. North America
      1. North America Cardiac Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
      2. North America Cardiac Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Myocardial Infarction
        3. Congestive Heart Failure
        4. Others
      3. North America Cardiac Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
        2. Point of Care Testing
        3. Others
      4. U.S.
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      5. Canada
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
    2. Europe
      1. Europe Cardiac Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
      2. Europe Cardiac Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Myocardial Infarction
        3. Congestive Heart Failure
        4. Others
      3. Europe Cardiac Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
        2. Point of Care Testing
        3. Others
      4. U.K.
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      5. Germany
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      6. France
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      7. Spain
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      8. Italy
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      9. Russia
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      10. Nordic
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      11. Benelux
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      12. Rest of Europe
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
    3. APAC
      1. APAC Cardiac Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
      2. APAC Cardiac Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Myocardial Infarction
        3. Congestive Heart Failure
        4. Others
      3. APAC Cardiac Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
        2. Point of Care Testing
        3. Others
      4. China
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      5. Korea
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      6. Japan
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      7. India
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      8. Australia
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      9. Taiwan
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      10. South East Asia
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      11. Rest of Asia-Pacific
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
    4. Middle East and Africa
      1. Middle East and Africa Cardiac Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
      2. Middle East and Africa Cardiac Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Myocardial Infarction
        3. Congestive Heart Failure
        4. Others
      3. Middle East and Africa Cardiac Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
        2. Point of Care Testing
        3. Others
      4. UAE
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      5. Turkey
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      6. Saudi Arabia
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      7. South Africa
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      8. Egypt
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      9. Nigeria
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      10. Rest of MEA
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
    5. LATAM
      1. LATAM Cardiac Biomarkers Market By Type 2022-2034 (USD MILLION/ Units)
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
      2. LATAM Cardiac Biomarkers Market By Application 2022-2034 (USD MILLION/ Units)
        1. Acute Coronary Syndrome
        2. Myocardial Infarction
        3. Congestive Heart Failure
        4. Others
      3. LATAM Cardiac Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Laboratory Testing
        2. Point of Care Testing
        3. Others
      4. Brazil
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      5. Mexico
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      6. Argentina
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      7. Chile
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      8. Colombia
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
      9. Rest of LATAM
        1. Myocardial Muscle Creatine Kinase (CK-MB)
        2. Troponins (T and I)
        3. Myoglobin
        4. Others
        5. Acute Coronary Syndrome
        6. Myocardial Infarction
        7. Congestive Heart Failure
        8. Others
        9. Laboratory Testing
        10. Point of Care Testing
        11. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.